Mazelsky Jonathan Jay's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Nov 16, 2022
- Accession no.
- 0001567619-22-020466
- Filed
- Nov 16, 2022
- Trade date
- Nov 14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.56M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazelsky Jonathan JayCIK 0001556270 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | MOption exerciseAcquired | +18,998 | $62.00 | +$1,177,876 | 81,304.64 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −972 | $433.37F1 | −$421,235.64 | 80,332.64 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −6,385 | $434.26F2 | −$2,772,750.1 | 73,947.64 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −2,543 | $435.07F3 | −$1,106,383.01 | 71,404.64 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −600 | $435.88F4 | −$261,528 | 70,804.64 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | MOption exerciseDisposed | −18,998 | –F6 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average price of the shares sold ranging from a low of $432.67 to a high of $433.65 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents the weighted average price of the shares sold ranging from a low of $433.69 to a high of $434.685 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of the shares sold ranging from a low of $434.70 to a high of $435.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold ranging from a low of $435.77 to a high of $436.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Not applicable.
Referenced by the price of 1 transaction in Table II.